Kymera Therapeutics · 3 days ago
Associate Director or Director, Regulatory Affairs
Kymera Therapeutics is a clinical-stage biotechnology company focused on developing targeted protein degradation medicines. The Associate Director or Director of Regulatory Affairs will play a key role in developing and executing global regulatory strategies for immunology treatments, working closely with the Global Program Regulatory lead.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Develop and execute on innovative and creative global regulatory strategies
Work across multiple indications and development programs within the STAT6 program
Leverage hands-on experiences developing immunology treatments to help advance Kymera’s I/I portfolio of targeted protein degraders
Qualification
Required
Bachelor's degree in a scientific discipline; Advanced degree preferred, but not required
8+ years of Regulatory Affairs experience, ideally in immunology and inflammation indications and including direct experience supporting the design and execution of pediatric drug development plans
Experience in directly authoring a broad range of regulatory submissions including briefing documents, Module 2 summaries, and designation requests
Demonstrated ability to independently coordinate and drive cross functional teams to develop complex regulatory submissions with successful outcomes
Experience in small molecule mid- and late-stage drug development is required
Excellent understanding and knowledge of global drug development and regulatory principles and practices with the motivation to continually learn and build on existing skills and knowledge base
Demonstrated ability to lead teams, internal and external, through excellent interpersonal and communication skills
A self-starter willing to take on new challenges, work outside their areas of comfort and collaborate cross functionally to contribute to the success of their programs
Benefits
Eligibility for annual bonus
Equity participation
Comprehensive benefits
Company
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Funding
Current Stage
Public CompanyTotal Funding
$1.96BKey Investors
Biotechnology Value FundAtlas Venture
2025-12-10Post Ipo Equity· $602M
2025-06-26Post Ipo Equity· $250.8M
2024-08-19Post Ipo Equity· $225M
Leadership Team
Recent News
2025-12-11
Company data provided by crunchbase